{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:04:53Z","timestamp":1791482693219,"version":"4.3.4"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>In pre\u2010eclampsia models, nicotinamide (NAM) has protective effects in pre\u2010eclampsia and is being evaluated as a therapeutic nutraceutical in clinical studies. NAM undergoes extensive hepatic metabolism by NAM N\u2010methyltransferase to methylnicotinamide (MNA), which is subsequently metabolized to methyl\u20102\u2010pyridone\u20105\u2010carboxamide (M2PY) by aldehyde oxidase. However, the pharmacokinetics of NAM and its major metabolites has never been studied in pregnant individuals. Blood samples were collected before and 1, 2, 4, 8, and 24\u2009hours after single 1\u2009g oral NAM dose in healthy pregnant (gestational age 24\u201333\u2009weeks) and nonpregnant female volunteers (<jats:italic>n<\/jats:italic>\u2009=\u20096\/group). Pooled urine was collected from 0 to 8\u2009hours. NAM, MNA, and M2PY area under the concentration\u2010time curve (AUC) data were analyzed by noncompartmental analysis. No difference in the plasma AUC<jats:sub>0\u219224<\/jats:sub> of NAM (median (25%\u201375%): 463 (436\u2013576) vs. 510 (423, 725) \u03bcM*hour, <jats:italic>P<\/jats:italic>\u2009=\u20090.430) and its intermediate metabolite MNA (89.1 (60.4, 124.4) vs. 83.8 (62.7, 93.7) \u03bcM*hour, <jats:italic>P<\/jats:italic>\u2009=\u20090.515) was observed in pregnant and nonpregnant volunteers, respectively; however, the terminal metabolite M2PY AUC<jats:sub>0\u2009\u2192\u200924<\/jats:sub> was significantly lower in pregnant individuals (218 (188, 254) vs. 597 (460, 653) \u03bcM*hour, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). NAM renal clearance (CL<jats:sub>R<\/jats:sub>; <jats:italic>P<\/jats:italic>\u2009=\u20090.184), MNA CL<jats:sub>R<\/jats:sub> (<jats:italic>P<\/jats:italic>\u2009=\u20090.180), and total metabolite formation clearance (<jats:italic>P<\/jats:italic>\u2009=\u20090.405) did not differ across groups; however, M2PY CL<jats:sub>R<\/jats:sub> was significantly higher in pregnant individuals (10.5 (9.3\u201311.3) vs. 7.5 (6.4\u20138.5) L\/h, <jats:italic>P<\/jats:italic>\u2009=\u20090.002). These findings demonstrate that the PK of NAM and systemic exposure to its intermediate metabolite MNA are not significantly altered during pregnancy, and systemic exposure to NAM's major metabolite M2PY was reduced during pregnancy due to increased renal elimination.<\/jats:p>","DOI":"10.1002\/cpt.3146","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T08:20:35Z","timestamp":1702542035000},"page":"556-564","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Pregnancy on the Pharmacokinetics and Metabolism of Nicotinamide in Humans"],"prefix":"10.1002","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-8585","authenticated-orcid":false,"given":"Muluneh M.","family":"Fashe","sequence":"first","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien V.","family":"Le","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan N.","family":"Gower","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-2195","authenticated-orcid":false,"given":"Ian R.","family":"Mulrenin","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen F.","family":"Dorman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynecology, School of Medicine University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spenser","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1848-0121","authenticated-orcid":false,"given":"John K.","family":"Fallon","sequence":"additional","affiliation":[{"name":"Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-5819","authenticated-orcid":false,"given":"Julie B.","family":"Dumond","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Boggess","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynecology, School of Medicine University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-5301","authenticated-orcid":false,"given":"Craig R.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056589"},{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180420"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1604-4"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506197"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178646918776658"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051536"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018101058"},{"issue":"5","key":"e_1_2_10_8_1","first-page":"1","article-title":"Final report of the safety assessment of niacinamide and niacin","volume":"24","author":"Cosmetic Ingredient Review Expert Panel","year":"2005","journal-title":"Int. J. Toxicol."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.2.152"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.309"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(92)90193-X"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(98)00048-6"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(93)90133-S"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8110339"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.02.004"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007300264"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.073841"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020437"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.138"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1770-2"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113829"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.36.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014445329756"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00501.2016"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614947113"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.244.243"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313276"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1084"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.2002845"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.382"},{"key":"e_1_2_10_32_1","volume-title":"Study of Nicotinamide in Early Onset Preeclampsia","author":"Boggess K.","year":"2022"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2012.07.030"},{"key":"e_1_2_10_34_1","volume-title":"Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application","author":"U.S. Food and Drug Administration","year":"2021"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1004010"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1218703"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr4004213"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21540"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/164844b0"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.049734"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03698.x"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01062963"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.01.012"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-01099-1"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm900403j"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003260336"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01908.x"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707383"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-012-8257-x"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2010.06.003"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.3146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T15:43:19Z","timestamp":1708098199000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.3146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1002\/cpt.3146"],"URL":"https:\/\/doi.org\/10.1002\/cpt.3146","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"2023-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}